Veterinary Medicines

Hyobac App6 Vet. injektionsvæske, emulsion

Authorised
  • Actinobacillus pleuropneumoniae, serovar 6, strain WSLB 3075, Inactivated
  • Actinobacillus pleuropneumoniae, serovar 6, strain WSLB 3075, APX II toxoid
  • Actinobacillus pleuropneumoniae, serovar 6, strain WSLB 3075, APX III toxoid
Download as PDF

Product identification

Medicine name:
Hyobac App6 Vet. injektionsvæske, emulsion
Hyobac App6 Vet. injektionsvæske, emulsion
Active substance:
  • Actinobacillus pleuropneumoniae, serovar 6, strain WSLB 3075, Inactivated
  • Actinobacillus pleuropneumoniae, serovar 6, strain WSLB 3075, APX II toxoid
  • Actinobacillus pleuropneumoniae, serovar 6, strain WSLB 3075, APX III toxoid
Target species:
  • Pig
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Actinobacillus pleuropneumoniae, serovar 6, strain WSLB 3075, Inactivated
    1.00
    relative potency
    /
    1.00
    millilitre(s)
  • Actinobacillus pleuropneumoniae, serovar 6, strain WSLB 3075, APX II toxoid
    1.00
    relative potency
    /
    1.00
    millilitre(s)
  • Actinobacillus pleuropneumoniae, serovar 6, strain WSLB 3075, APX III toxoid
    1.00
    relative potency
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Emulsion for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Pig
      • Meat and offal
        0
        day
      • Meat and offal
        0
        day
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI09AB07
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Denmark
Available in:
  • Denmark
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Salfarm Danmark A/S
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bioveta a.s.
Responsible authority:
  • Danish Medicines Agency
Authorisation number:
  • 54385
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Danish (, INJEKTIONSVÆSKE, EMULSION)
Published on: 7/04/2025
Download